[go: up one dir, main page]

AU2023901437A0 - Self-adjuvanting VLP and uses thereof - Google Patents

Self-adjuvanting VLP and uses thereof

Info

Publication number
AU2023901437A0
AU2023901437A0 AU2023901437A AU2023901437A AU2023901437A0 AU 2023901437 A0 AU2023901437 A0 AU 2023901437A0 AU 2023901437 A AU2023901437 A AU 2023901437A AU 2023901437 A AU2023901437 A AU 2023901437A AU 2023901437 A0 AU2023901437 A0 AU 2023901437A0
Authority
AU
Australia
Prior art keywords
adjuvanting
vlp
self
adjuvanting vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2023901437A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2023901437A0 publication Critical patent/AU2023901437A0/en
Abandoned legal-status Critical Current

Links

AU2023901437A 2023-05-11 Self-adjuvanting VLP and uses thereof Abandoned AU2023901437A0 (en)

Publications (1)

Publication Number Publication Date
AU2023901437A0 true AU2023901437A0 (en) 2023-05-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096651A4 (en) Compounds and uses thereof
EP4247815A4 (en) Compounds and uses thereof
EP4165049A4 (en) Isotryptamine psychoplastogens and uses thereof
AU2021401426A9 (en) Fap-activated radiotheranostics, and uses related thereto
EP4337211A4 (en) Compounds and uses thereof
AU2023901437A0 (en) Self-adjuvanting VLP and uses thereof
AU2021902406A0 (en) Self-adjuvanting VLP and uses thereof
CA3276902A1 (en) Substituted trianglamine and uses thereof
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
CA3278890A1 (en) Substituted spirocyclic-pyrroloquinazolinones and spirocyclic-piperidinoquinazolinones
HK40122749A (en) Lincosamides and uses thereof
HK40108849A (en) Nitrophenyl-acrylamides and uses thereof
CA3270830A1 (en) Compounds and uses thereof
HK40123856A (en) Compounds and uses thereof
HK40082393A (en) Deoptimized sars-cov-2 and methods and uses thereof
HK40115042A (en) Lurbinectedin and atezolizumab combinations
AU2022901438A0 (en) Methods and materials
HK40103828A (en) Sulfonimidamide compounds and uses thereof
AU2022903599A0 (en) Pharmaceutical combinations and uses thereof
HK40114381A (en) Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses
HK40084386A (en) Substituted pyrazolo-pyrimidines and uses thereof
AU2020904717A0 (en) Methods and Compositions-II
AU2023903496A0 (en) Lixiviant and uses thereof
HK40119201A (en) Nanobody-drug adducts and uses thereof
CA3262048A1 (en) Cx3cr1-binding compounds, methods and uses thereof